BCYC
Bicycle Therapeutics plc
NASDAQ · Healthcare · Biotechnology · GB
$4.30
+1.42%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.75x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.59x
- Price / sales
- 4.92x
- Price / cash flow
- -1.46x
Enterprise value
- Enterprise value
- -$195.4M
- EV / sales
- -3.19x
- EV / EBITDA
- 1.07x
- EV / EBIT
- 0.93x
- Market cap
- $301.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026